User profiles for Jacobus J. van Hilten

Jacobus J van Hilten

Hoogleraar Neurologie, Leiden University Medical Center
Verified email at lumc.nl
Cited by 42200

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

…, A Schrag, JA Teresi, JJ van Hilten… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan

…, A Schrag, JA Teresi, JJ Van Hilten… - Movement …, 2007 - Wiley Online Library
This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA‐AUT

…, AM Stiggelbout, JJ Van Hilten - … : official journal of the …, 2004 - Wiley Online Library
We developed a questionnaire to assess autonomic symptoms in patients with Parkinson's
disease (PD) and evaluated its reliability and validity. Based on the results of a postal survey …

Clinical features and pathophysiology of complex regional pain syndrome

…, C Maihöfner, WS Kingery, JJ van Hilten - The Lancet …, 2011 - thelancet.com
A complex regional pain syndrome (CRPS)—multiple system dysfunction, severe and often
chronic pain, and disability—can be triggered by a minor injury, a fact that has fascinated …

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1

…, JJ Van Hilten, MCR Bauer, MS Arbous, J Marinus… - Pain, 2009 - Elsevier
Complex Regional Pain Syndrome Type 1 (CRPS-1) responds poorly to standard pain
treatment. We evaluated if the N-methyl-d-aspartate receptor antagonist S(+)-ketamine improves …

Assessment of sleep and sleepiness in Parkinson disease

J Marinus, M Visser, JJ van Hilten, GJ Lammers… - Sleep, 2003 - academic.oup.com
Study Objectives: To develop a short and practical scale (SCOPA-SLEEP) that evaluates
nighttime sleep and daytime sleepiness. The scale is developed for research in Parkinson …

Patient-reported autonomic symptoms in Parkinson disease

…, SM van Rooden, AM Stiggelbout, JJ van Hilten - Neurology, 2007 - AAN Enterprises
Objective: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but
the full spectrum has never been evaluated with a validated instrument and in comparison …

[PDF][PDF] Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy

…, E Gray, R Guerreiro, C Harris, JJ van Hilten… - The American Journal of …, 2016 - cell.com
Autosomal-recessive early-onset parkinsonism is clinically and genetically heterogeneous.
The genetic causes of approximately 50% of autosomal-recessive early-onset forms of …

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

…, Ó Gústafsson, C Harris, JJ van Hilten… - Proceedings of the …, 2014 - National Acad Sciences
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause inherited Parkinson disease (PD),
and common variants around LRRK2 are a risk factor for sporadic PD. Using protein–protein …

Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments

J Marinus, C Ramaker, JJ van Hilten… - Journal of neurology …, 2002 - jnnp.bmj.com
Objective: To compare and contrast disease-specific quality of life instruments in Parkinson's
disease and assess their clinimetric properties. Methods: Two reviewers independently …